Clinical Trials
4
Active:0
Completed:3
Trial Phases
3 Phases
Phase 1:1
Phase 3:1
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Not Applicable
1 (33.3%)Phase 1
1 (33.3%)Phase 3
1 (33.3%)Impact of Physical Activity in Vascular Cognitive Impairment ( AFIVASC )
Not Applicable
Completed
- Conditions
- Vascular Cognitive Impairment
- First Posted Date
- 2018-07-06
- Last Posted Date
- 2021-04-01
- Target Recruit Count
- 104
- Registration Number
- NCT03578614
- Locations
- 🇵🇹
Instituto de Medicina Molecular João Lobo Antunes, Lisboa, Portugal
A Phase 1/2 Trial of Donor Regulatory T-cells for Steroid-Refractory Chronic Graft-versus-Host-Disease
Phase 1
- Conditions
- Graft vs Host Disease
- First Posted Date
- 2015-03-11
- Last Posted Date
- 2018-03-06
- Target Recruit Count
- 22
- Registration Number
- NCT02385019
- Locations
- 🇵🇹
Instituto Portugues de Oncologia, Porto, Portugal
🇵🇹Hospital de Santa Maria, Faculdade de Medicina da Universidade de Lisboa, Instituto de Medicina Molecular, Lisboa, Portugal
Efficacy of Golimumab in Combination With Methotrexate (MTX) Versus MTX Monotherapy, in Improving Dactylitis, in MTX naïve Psoriatic Arthritis Patients
Phase 3
Completed
- Conditions
- Psoriatic Arthritis
- Interventions
- First Posted Date
- 2014-02-19
- Last Posted Date
- 2020-11-13
- Target Recruit Count
- 44
- Registration Number
- NCT02065713
- Locations
- 🇵🇹
Centro Académico de Medicina de Lisboa, Lisbon, Portugal
Differences in Bone Cell Activity Between Rheumatoid Arthritis and Ankylosing Spondylitis
Completed
- Conditions
- Rheumatoid ArthritisAnkylosing SpondylitisBone Resorption
- First Posted Date
- 2011-08-16
- Last Posted Date
- 2016-03-21
- Target Recruit Count
- 101
- Registration Number
- NCT01417455
- Locations
- 🇵🇹
Instituto de Medicina Molecular, Lisbon, Portugal
News
No news found